S100A9 induces neuroinflammation and aggravates early brain injury after subarachnoid hemorrhage by activating the TLR4/MYD88/NF-κB pathway
Guijun Wang,Kesheng Huang,Zhan Zhang,Yujia Guo,Qi Tian,Chengli Liu,Zhijie Li,Zhui Yu,Mingchang Li
DOI: https://doi.org/10.1101/2023.03.09.23287076
2023-01-01
Abstract:Background Subarachnoid hemorrhage (SAH) is a stroke subtype with an extremely high mortality rate, and its severity is closely related to the short-term prognosis of patients with SAH. The S100 calcium-binding protein A9 (S100A9) has been shown to be associated with some neurological diseases, and this study aimed to investigate the relationship between S100A9 and neuroinflammation, as well as its mechanism in SAH.
Methods An enzyme-linked immunosorbent assay (ELISA) was used to detect the concentration of S100A9 in clinical cerebrospinal fluid samples. Furthermore, an in vivo mouse SAH model was established using intravascular perforation; S100A9 knockout mice were used for the in vivo experiments. S100A9 recombinant protein was administered via lateral ventricular injection 1 h before SAH model induction. SAH grade, neurological function score, and brain water content were measured after a specific time. BV2 and HT22 cells and co-culture models were treated with heme chloride to establish an in vitro model of SAH. Paquinimod was used to explore the potential neuroprotective mechanisms of S100A9 inhibition. Western blotting and immunofluorescence staining were used to explore microglial activation, inflammatory responses, and its related protein pathways.
Results The expression of S100A9 protein in the cerebrospinal fluid of patients with SAH increased and was related to the short-term prognosis of patients with SAH; S100A9 was highly expressed in the microglia. S100A9 knockout significantly improved neurological function scores, reduced brain edema, and reduced neuronal apoptosis. S100A9 inhibition with Paquinimod restrained neuronal apoptosis, while administration of recombinant S100A9 aggravated neuroinflammation, activated the TLR4 receptor, promoted NF-κB nuclear transcription, and ultimately aggravated nerve injury.
Conclusion S100A9 protein expression increased after SAH, which induced neuroinflammation and promote neuronal apoptosis by activating the TLR4/MYD88/ NF-κB pathway, ultimately aggravating nerve injury after SAH.
### Competing Interest Statement
The authors have declared no competing interest.
### Funding Statement
This work was supported by National Natural Science Foundation of China (Grant /Award Number: 81971870, 82172173 to Mingchang Li).
### Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All animal experiments were approved by the Animal Experiment Center of Wuhan University.The clinical samples were approved by the Ethics Committee of Renmin Hospital of Wuhan University (WDRY2021-K070)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
All raw data is provided as required.
* SAH
: subarachnoid hemorrhage
ELISA
: enzyme-linked immunosorbent assay
TLR4
: toll-like receptor 4
EBI
: early brain injury
BBB
: blood-brain barrier
PAMP
: pathogen-associated molecular pattern
DAMP
: damage-associated molecular pattern
PRRs
: Pattern recognition receptors
HSP
: heat-shock protein
HMGB1
: high mobility group protein B1
RAGE
: receptor for advanced glycation end products
PBS
: phosphate buffer solution
MYD88
: myeloid differentiation factor 88
IL-1β
: interleukin-1β
TNF-α
: tumor necrosis factor
WT
: wild-type
Sham
: sham-operated
PFA
: paraformaldehyde
DAPI
: 4-6-diamidino-2-phenylindole
ECL
: enhanced chemiluminescence
CA
: cornu smmonis
CSF
: cerebrospinal fluid